A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome

Francois Parquin, Benjamin Zuber, Alexandre Vallée, Jean-Luc Taupin, Elise Cuquemelle, Stéphanie Malard, Mathilde Neuville, Jérôme Devaquet, Morgan Le Guen, Julien Fessler, Laurence Beaumont, Clément Picard, Abdulmonem Hamid, Sylvie Colin de Verdière, Dominique Grenet, Sandra De Miranda, Matthieu Glorion, Edouard Sage, Ciprian Pricopi, Julien De Wolf, Anne-Laure Brun, Elisabeth Longchampt, Charles Cerf, Antoine Roux, Olivier Brugière

Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020
Journal Issue: November

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Francois Parquin, Benjamin Zuber, Alexandre Vallée, Jean-Luc Taupin, Elise Cuquemelle, Stéphanie Malard, Mathilde Neuville, Jérôme Devaquet, Morgan Le Guen, Julien Fessler, Laurence Beaumont, Clément Picard, Abdulmonem Hamid, Sylvie Colin de Verdière, Dominique Grenet, Sandra De Miranda, Matthieu Glorion, Edouard Sage, Ciprian Pricopi, Julien De Wolf, Anne-Laure Brun, Elisabeth Longchampt, Charles Cerf, Antoine Roux, Olivier Brugière. A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome. Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016

The impact of pre-transplant donor specific anti-HLA antibodies (DSAs) on lung transplant outcome: A single center experience
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

Short and mid-term outcomes of lung transplant recipients with COVID-19
Source: Virtual Congress 2021 – Challenging problems in lung transplantation
Year: 2021


Outcome of lung retransplantation: from graft survival to patients’ perspective
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020


Positive impact of tacrolimus-based immunosuppression after lung transplantation – an analysis of potential risk factors for long-term survival
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007


CMV management in lung transplant recipients
Source: School Course 2012 - Lung Transplantation
Year: 2012


Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation
Source: Eur Respir J, 50 (5) 1701248; 10.1183/13993003.01248-2017
Year: 2017



Donor and recipient parameters affecting 1-year follow-up after lung transplant: Padova experience
Source: Annual Congress 2011 - Lung transplantation
Year: 2011

Impact of donor, recipient and matching on survival after high emergency lung transplantation in France
Source: Eur Respir J, 54 (5) 1900096; 10.1183/13993003.00096-2019
Year: 2019



Longitudinal assessment of CD4+CD25highCD69- treg cells in a cohort of lung transplant recipients (LTR). An association with chronic graft rejection
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Predictors of survival of patients waiting for lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004

How to improve long-term outcomes following lung transplantation
Source: International Congress 2019 – Lung transplantation in 2019: where are we?
Year: 2019


Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018

Specificities of the paediatric lung transplant recipient
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


Analysis of the nasal microbiome in long-term survivors after lung transplantation with a good allograft function
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

Improving lung transplant outcomes in France: the high emergency lung transplantation programme
Source: Eur Respir J, 59 (1) 2102209; 10.1183/13993003.02209-2021
Year: 2022



Extracorporeal photoapheresis in the treatment of chronic lung rejection: preliminary clinical and immunological results on a small cohort of lung recipients
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008

Long-term follow-up of lung transplant recipients with obstructive airway complications
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Single centre lung transplant experience of customised biodegradable stents in the early post-lung transplant period.
Source: Virtual Congress 2021 – Challenging problems in lung transplantation
Year: 2021